Investigations

The law firm of Kirby McInerney LLP is investigating potential claims against Accenture (“Accenture” or the “Company”) (NYSE:ACN). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP is investigating potential claims against ADTRAN Holdings, Inc. (“ADTRAN” or the “Company”) (NASDAQ: ADTN). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Alarum Technologies Ltd.  (“Alarum” or the “Company”) (NASDAQ: ALAR) common stock between March 20, 2025 and July 2, 2026, inclusive (“the Class Period”).

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Alibaba Group Holding Limited (“Alibaba” or the “Company”) (NYSE: BABA) common stock between June 26, 2025 and June 24, 2026, inclusive (“the Class Period”).

The law firm of Kirby McInerney LLP is investigating potential claims against Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (NASDAQ: ALHC). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP is investigating potential claims against Alnylam Pharmaceuticals, Inc. (“Alnylam” or the “Company”) (NASDAQ: ALNY). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP announces an investigation on behalf of Banc of California, Inc. (“Banc of California” or the “Company”) (NYSE: BANC) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX) securities during the period of July 30, 2025 through February 24, 2026, inclusive (“the Class Period”). Investors are encouraged to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
 

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Bloom Energy Corporation (“Bloom Energy” or the “Company”) (NYSE: BE) common stock between February 27, 2025 and July 8, 2026, inclusive (“the Class Period”).

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) common stock between December 17, 2025 and July 26, 2026, inclusive (“the Class Period”).

The law firm of Kirby McInerney LLP is investigating potential claims against Celcuity Inc. (“Celcuity” or the “Company”) (Nasdaq: CELC). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP is investigating potential claims against Coastal Financial Corporation (“Coastal” or the “Company”) (NASDAQ: CCB). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP is investigating potential claims against Criteo S.A. (“Criteo” or the “Company”) (NASDAQ: CRTO). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. 
 

The law firm of Kirby McInerney LLP is investigating potential claims against Dick’s Sporting Goods, Inc. (“Dick’s” or the “Company”) (NYSE: DKS). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. If you purchased or otherwise acquired Dick’s securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.
 

The law firm of Kirby McInerney LLP is investigating potential claims against Dr. Reddy’s Laboratories (“Dr. Reddy’s” or the “Company”) (NYSE: RDY). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP is investigating potential claims against EyePoint Pharmaceuticals (“EyePoint” or the “Company”) (NASDAQ:  EYPT). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. 
 

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired FuelCell Energy, Inc. (“FuelCell” or the “Company”) (NASDAQ: FCEL) securities between June 24, 2026 and September 1, 2026, inclusive (“the Class Period”). If you suffered a loss on your FuelCell investments, you have until November 10, 2026 to request lead plaintiff appointment.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired GoDaddy Inc. (“GoDaddy” or the “Company”) (NYSE: GDDY) securities during the period of September 3, 2025 through February 24, 2026, inclusive (“the Class Period”). 
 

The law firm of Kirby McInerney LLP is investigating potential claims against HCA Healthcare, Inc. (“HCA Healthcare” or the “Company”) (NYSE: HCA). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired HDFC Bank Limited (“HDFC” or the “Company”) (NYSE: HDB) securities during the period of July 17, 2023 through May 26, 2026, inclusive (“the Class Period”). 

The law firm of Kirby McInerney LLP is investigating potential claims against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Innventure, Inc. (“Innventure” or the “Company”) (NASDAQ: INV) securities during the period of November 17, 2025 through August 13, 2026, inclusive (“the Class Period”). 

The law firm of Kirby McInerney LLP is investigating potential claims against Jefferies Financial Group, Inc. (“Jefferies” or the “Company”) (NYSE: JEF). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. 

The law firm of Kirby McInerney LLP is investigating potential claims against Kemper Corporation (“Kemper” or the “Company”) (NYSE:KMPR). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Lincoln Educational Services Corporation (“Lincoln” or the “Company”) (NASDAQ: LINC) securities between May 11, 2026 and August 9, 2026, inclusive (“the Class Period”). If you suffered a loss on your Lincoln investments, you have until November 10, 2026 to request lead plaintiff appointment.
 

The law firm of Kirby McInerney LLP is investigating potential claims against MercadoLibre, Inc. (“MercadoLibre” or the “Company”) (NASDAQ:MELI). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP is investigating potential claims against Myriad Genetics, Inc. (“Myriad Genetics” or the “Company”) (NASDAQ: MYGN). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP is investigating potential claims against Noble Corporation plc (“Noble” or the “Company”) (NYSE: NE). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP is investigating potential claims against OSI Systems, Inc. (“OSI” or the “Company”) (NASDAQ: OSIS). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. If you purchased or otherwise acquired OSI securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.
 

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Park Ha Biological Technology Co., Ltd. (“PHH” or the “Company”) (NASDAQ:BYAH) securities during the period of December 24, 2024 through July 8, 2025, inclusive (“the Class Period”).

The law firm of Kirby McInerney LLP is investigating potential claims against Pathward Financial, Inc. (“Pathward” or the “Company”) (NASDAQ: CASH). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Pentair plc (“Pentair” or the “Company”) (NYSE: PNR) common stock between March 11, 2025 and July 14, 2026, inclusive (“the Class Period”).

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Rackspace Technology, Inc. (“Rackspace” or the “Company”) (NASDAQ: RXT) common stock between May 7, 2026 and July 8, 2026, inclusive (“the Class Period”).

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL) common stock between October 20, 2025 and April 10, 2026, inclusive (“the Class Period”).

The law firm of Kirby McInerney LLP is investigating potential claims against Rollins, Inc. (“Rollins” or the “Company”) (NYSE: ROL). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired The Simply Good Foods Company (“Good Foods” or the “Company”) (NASDAQ: SMPL) securities during the period of October 24, 2024 through April 8, 2026, inclusive (“the Class Period”). 
 

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who sold Smartsheet Inc. (“Smartsheet” or the “Company”) (Other: SMAR) common stock between June 1, 2024 and September 23, 2024, inclusive (“the Class Period”).

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Taboola.com Ltd (“Taboola” or the “Company”) (NASDAQ: TBLA) securities during the period of May 6, 2026 through August 4, 2026, inclusive (“the Class Period”).
 

The law firm of Kirby McInerney LLP is investigating potential claims against The Cooper Companies, Inc. (“CooperCompanies” or the “Company”) (NASDAQ: COO). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired CooperCompanies securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.
 

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Unicycive Therapeutics (“Unicycive” or the “Company”) (NADAQ: UNCY) securities during the period of December 29, 2025 through June 29, 2026, inclusive (“the Class Period”). Investors are encouraged to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Wise Group plc (“Wise” or the “Company”) (NASDAQ: WSE) common stock between May 11, 2026 and July 23, 2026, inclusive (“the Class Period”).

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired York Space Systems Inc. (“York” or the “Company”) (NYSE: YSS): (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s January 29, 2026 initial public offering (“IPO” or the “Offering”); and/or (b) securities during the period of January 29, 2026 through May 11, 2026, inclusive (“the Class Period”).